EUVIMEDEUVIMED entdecken
Crossref

m6A reader YTHDF3 is associated with clinical prognosis, related RNA signatures and immunosuppression in gastric cancer

Yi Yu, Li-Li Meng, Xiao-Yu Chen, Hui-Ning Fan, Ming Chen, Jing Zhang, Jin-Shui Zhu

Cellular Signalling · 2023

DOI: 10.1016/j.cellsig.2023.110699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2023. Verfasst von Yi Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, Chi…. Hauptthemen laut MEDLINE: Adenocarcinoma, MicroRNAs, Stomach Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, School of Medicine, Shanghai Jiao Tong University, Natural Science Foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: YTHDF3 as a N6-methyladenosine (m6A) reader participates in the development and progression of multiple cancer types, however, the prognosis, molecular biology and immune infiltration of YTHDF3 in gastric cancer (GC) have not been investigated. METHODS: The YTHDF3 expression profile and clinicopathological parameters of stomach adenocarcinoma (STAD) were downloaded from TCGA. The online websites and databases such as GEPIA2, cBioPortal, UALCAN, ImmuCellAl, xCell, TISIDB, GSCA were utilized for analysis of the association of YTHDF3 with STAD, including clinical prognosis, WGCNA and LASSO Cox regression analysis. Further functional assays such as RT-qPCR, Western blot, immunohistochemistry (IHC), immunofluorescence (IF), CCK-8, colony formation, EdU and Transwell assays were performed to determine the role of YTHDF3 in GC. RESULTS: We found that YTHDF3 was upregulated in STAD tissue samples ascribed to its copy number amplification and associated with poor prognosis in patients with STAD. GO and KEGG analyses showed that YTHDF3-related differential genes were predominantly enriched in the proliferation, metabolism and immune signaling pathways. Knockdown of YTHDF3 repressed the growth and invasion of GC cells by inhibition of PI3K/AKT signaling. We then identified YTHDF3-related lncRNAs, miRNAs and mRNAs, and constructed their prognostic signatures in patients with STAD. Moreover, YTHDF3 associated with tumor immune infiltration such as CD8+ T cells, macrophages, Tregs, MHC molecules and chemokines, upregulated PD-L1 and CXCL1 and exerted a response to the immunotherapy in GC. CONCLUSIONS: YTHDF3 upregulation indicates poor prognosis and promotes GC cell growth and invasion by activating PI3K/AKT pathway and regulating immune microenvironment. The established YTHDF3-related signatures highlight the association of YTHDF3 with the clinical prognosis and immune cell infiltration in GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaMicroRNAsStomach NeoplasmsHumansImmunosuppression TherapyPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTumor MicroenvironmentRNA-Binding Proteins

Stichwörter der Autor:innen

Gastric cancerPD-L1PrognosisTumor-immune microenvironmentYTHDF3

Substanzen

MicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktYTHDF3 protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Gastroenterology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
  • Department of Pathology, Zhongshan Hospital, Fudan University, China.
  • Department of Gastroenterology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China. Electronic address: jing5522724@vip.163.com.
  • Department of Gastroenterology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China. Electronic address: zhujs1803@163.com.

Förderung

  • National Natural Science Foundation of China
  • School of Medicine, Shanghai Jiao Tong University
  • Natural Science Foundation of Shanghai

Zitieren

APA

Yu, Y., Meng, L. L., Chen, X. Y., Fan, H. N., Chen, M., Zhang, J., & Zhu, J. S. (2023). m6A reader YTHDF3 is associated with clinical prognosis, related RNA signatures and immunosuppression in gastric cancer. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2023.110699

Vancouver

Yu Y, Meng LL, Chen XY, Fan HN, Chen M, Zhang J, et al. m6A reader YTHDF3 is associated with clinical prognosis, related RNA signatures and immunosuppression in gastric cancer. Cellular Signalling. 2023. doi:10.1016/j.cellsig.2023.110699

BibTeX
@article{Yu2023,
  author = {Yu, Yi and Meng, Li-Li and Chen, Xiao-Yu and Fan, Hui-Ning and Chen, Ming and Zhang, Jing and Zhu, Jin-Shui},
  title = {m6A reader YTHDF3 is associated with clinical prognosis, related RNA signatures and immunosuppression in gastric cancer},
  journal = {Cellular Signalling},
  year = {2023},
  doi = {10.1016/j.cellsig.2023.110699}
}
Kostenlos starten →